Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Panayiotou A et al. Lipid fractions with aggregatory and antiaggregatory activity toward platelets in fresh and fried cod (Gadus morhua): correlation with platelet-activating factor and atherogenesis. 2000 J. Agric. Food Chem. pmid:11312810
Chen LW et al. Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. 2000 Shock pmid:10718373
Manabe H et al. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. 2000 Pulm Pharmacol Ther pmid:10718985
Sun Z et al. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. 2000 Dig Surg pmid:10720833
Vallee RB et al. The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. 2000 Biochim. Biophys. Acta pmid:10722879
Kimura I et al. Release of endothelins and platelet-activating factor by a rat pleural mesothelial cell line. 2000 Eur. Respir. J. pmid:10678641
Orozco AS et al. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. 2000 Infect. Immun. pmid:10678917
Ishihara Y et al. Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. 2000 Infect. Immun. pmid:10678975
Fujimura M et al. No involvement of lipid mediators in a guinea pig model of ultrasonically nebulized distilled water-induced bronchoconstriction. 2000 Prostaglandins Other Lipid Mediat. pmid:10680775
Sugano T et al. Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts. 2000 Biol. Reprod. pmid:10684793
Fukuda Y et al. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models. 2000 Eur. J. Pharmacol. pmid:10708725
Neuberger Y et al. A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum. 2000 FEBS Lett. pmid:10708753
Baker RR and Chang HY The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: the control of nuclear lyso platelet-activating factor metabolism. 2000 Mol. Cell. Biochem. pmid:11204449
Mannori G et al. Interaction of tumor cells with vascular endothelia: role of platelet-activating factor. 2000 Clin. Exp. Metastasis pmid:11206844
Herrero-Fresneda I et al. Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. 2000 Transplantation pmid:11190497
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Grimminger F et al. PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10666110
Berthou C et al. Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. 2000 Blood pmid:10733503
Kaul DK et al. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. 2000 Blood pmid:10627437
Franke B et al. Sequential regulation of the small GTPase Rap1 in human platelets. 2000 Mol. Cell. Biol. pmid:10629034
Haines DD et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. 2000 J. Cardiovasc. Pharmacol. pmid:10630731
Fukuda S et al. Mechanisms for regulation of fluid shear stress response in circulating leukocytes. 2000 Circ. Res. pmid:10625314
Kim DD et al. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch. 2000 Microvasc. Res. pmid:10625566
Montrucchio G et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10634803
Zaitseva L et al. Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock. 2000 Bull. Exp. Biol. Med. pmid:11177271
Kecskeméti V and Balogh I The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. 2000 J. Physiol. Pharmacol. pmid:11192945
Adams JM et al. G-protein receptor responses in trauma neutrophils. 2000 J Trauma pmid:11130495
Asimakopoulos G et al. Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin. 2000 Perfusion pmid:11131212
Burns AR et al. Analysis of tight junctions during neutrophil transendothelial migration. 2000 J. Cell. Sci. pmid:10591624
Luu NT et al. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils. 2000 J. Immunol. pmid:10820279
Sugatani J et al. Inhibition of rabbit platelet aggregation by nucleoside 5'-alkylphosphates: correlation with inhibition of agonist-induced calcium influx. 2000 Biochem. Pharmacol. pmid:10825464
McManus LM and Pinckard RN PAF, a putative mediator of oral inflammation. 2000 Crit. Rev. Oral Biol. Med. pmid:12002818
Ohishi S [Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction]. 2000 Yakugaku Zasshi pmid:10825809
Asai Y et al. Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). 2000 Drug Dev Ind Pharm pmid:10826115
Desplat V et al. Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. 2000 Cancer Lett. pmid:10737702
Boccellino M et al. Effect of platelet-activating factor receptor expression on CHO cell motility. 2000 J. Cell. Physiol. pmid:10737901
Liao CH et al. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. 2000 J. Pharm. Pharmacol. pmid:10757426
Hagi A et al. Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor. 2000 J. Med. Invest. pmid:10740976
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Logan JE and Roudebush WE Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos. 2000 Early Pregnancy pmid:11719820
Shindou H et al. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. 2000 Biochem. Biophys. Res. Commun. pmid:10814544
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Oshiro T et al. Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils. 2000 Clin. Exp. Allergy pmid:10792362
Ibe BO et al. Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10749711
Hauser CJ et al. Major trauma enhances store-operated calcium influx in human neutrophils. 2000 J Trauma pmid:10780589
Vincent JL et al. Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. 2000 Crit. Care Med. pmid:10752807
Lendvai N et al. Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. 2000 J. Immunol. pmid:10754337
Gu M et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. 2000 Transplantation pmid:11045637
Poeze M et al. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. 2000 Shock pmid:11049104
Karlstad MD et al. Platelet-activating factor (PAF)-induced decreases in whole-body and skeletal muscle protein synthesis. 2000 Shock pmid:11049115
Kalia N et al. Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. 2000 Dig. Dis. Sci. pmid:10759248
James JH and Fischer JE Are the effects of platelet-activating factor on muscle metabolism of carbohydrates, amino acids and proteins attributable mainly to epinephrine? 2000 Shock pmid:11049116
Dichmann S et al. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells. 2000 J. Cell. Physiol. pmid:11056009
Grassi S and Pettorossi VE Role of nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2000 Neuroscience pmid:11068144
Bussolati B et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. 2000 Am. J. Pathol. pmid:11073830
Koyama S et al. The potential of various lipopolysaccharides to release IL-8 and G-CSF. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10749742
Kelly RF Current strategies in lung preservation. 2000 J. Lab. Clin. Med. pmid:11128744
Alloatti G et al. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. 2000 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11080081
Tjoelker LW and Stafforini DM Platelet-activating factor acetylhydrolases in health and disease. 2000 Biochim. Biophys. Acta pmid:11080681
Tanaka Y et al. Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats. 2000 Br. J. Pharmacol. pmid:11082118
Chroni A and Mavri-Vavayanni M Characterization of a platelet activating factor acetylhydrolase from rat adipocyte. 2000 Life Sci. pmid:11105997
Wechsung E and Houvenaghel A Involvement of platelet activating factor in the endotoxin-induced effects on gastrointestinal electrical activity and some haematological parameters in the conscious miniature pig. 2000 J. Vet. Pharmacol. Ther. pmid:11107007
Lonardoni MV et al. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. 2000 Infect. Immun. pmid:11035745
Mul FP et al. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. 2000 J. Leukoc. Biol. pmid:11037975
Peri A et al. Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. 2000 Int. J. Cancer pmid:11058867
Tiano L et al. Oxidative response and membrane modification of diabetic platelets challenged with PAF. 2000 Prostaglandins Other Lipid Mediat. pmid:11060899
Bracco E et al. Cell-cell signaling and adhesion in phagocytosis and early development of Dictyostelium. 2000 Int. J. Dev. Biol. pmid:11061438
Biancone L et al. Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. 2000 Transplantation pmid:11063341
Okunuki H et al. Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice. 2000 Immunol. Lett. pmid:11064108
Toró A et al. Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. 2000 Org. Lett. pmid:10964353
Soeki T et al. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. 2000 Jpn. Circ. J. pmid:10952148
Henig NR et al. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. 2000 Am. J. Respir. Crit. Care Med. pmid:10934081
Haribabu B et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 2000 J. Exp. Med. pmid:10934231
Miyatake T et al. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. 2000 Transplant. Proc. pmid:10936319
Raible DG et al. Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. 2000 Free Radic. Biol. Med. pmid:10938462
Baskova I et al. Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. 2000 Platelets pmid:10938885
Pávó I et al. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. 2000 Eur. J. Pharmacol. pmid:10940373
Balestrieri ML and Lee T Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothlial cells. 2000 FEBS Lett. pmid:10940389
Gálvez J et al. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. 2000 Br. J. Pharmacol. pmid:10952687
Maniscalco M et al. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. 2000 Allergy pmid:10955702
Oktar BK et al. Endothelin-1-induced PMN infiltration and mucosal dysfunction in the rat small intestine. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10960346
Jeon SY et al. Ultrastructural changes in platelet activating factor-induced epithelial damage in rabbit maxillary sinus mucosa. 2000 Ann. Otol. Rhinol. Laryngol. pmid:10961804
Saito S et al. Modulatory roles of RANTES in IL-4 production by human blood CD4(+)T cells. 2000 Cytokine pmid:10975998
Tanaka R et al. Genetics of immunoglobulin A nephropathy. 2000 Ann. Acad. Med. Singap. pmid:10976391
Denizot Y et al. Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy. 2000 Nephrol. Dial. Transplant. pmid:10978389
Emingil G et al. Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A. 2000 J. Periodontol. pmid:10695938
Burgermeister E et al. Inhibition of cytosolic phospholipase A(2) attenuates activation of mitogen-activated protein kinases in human monocytic cells. 2000 Eur. J. Pharmacol. pmid:10675727
Folch E et al. H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. 2000 Free Radic. Biol. Med. pmid:10889459
Huo LJ and Yang ZM Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. 2000 Mol. Reprod. Dev. pmid:10862011
Cavallo-Perin P et al. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. 2000 Nephrol. Dial. Transplant. pmid:10862637
Bae K et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. 2000 J. Biol. Chem. pmid:10867005
Alappatt C et al. Acute keratinocyte damage stimulates platelet-activating factor production. 2000 Arch. Dermatol. Res. pmid:10867814
Suzuki S et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. 2000 Transplantation pmid:10868624
Serradji N et al. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication. 2000 J. Med. Chem. pmid:10841793
Ma X and Bazan HE Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10845588
Kobayashi N et al. Transepithelial migration of activated eosinophils induces a decrease of E-cadherin expression in cultured human nasal epithelial cells. 2000 Clin. Exp. Allergy pmid:10848899
Choi JH et al. Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. 2000 Inflammation pmid:10921504
Smalley DM et al. The local effect of PAF on leukocyte adherence to small bowel mesenteric venules following intra-abdominal contamination. 2000 Inflammation pmid:10921505
O'Brien JG et al. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. 2000 Inflammation pmid:10921506
Klyubin IV et al. The role of reactive oxygen species in membrane potential changes in macrophages and astrocytes. 2000 Membr Cell Biol pmid:10926373